HomeIndustriesHealthcareMesoblast CEO on FDA Approval, Development Pipeline
00:00
00:00
06:55
Mesoblast CEO on FDA Approval, Development Pipeline

Mesoblast CEO on FDA Approval, Development Pipeline

Dr. Silviu Itescu, CEO of the biotech company Mesoblast (MESO), joins Market On Close. The company is developing therapeutics using stem cells to target severe inflammatory conditions, including pediatric conditions. He discusses Mesoblast’s recent FDA approval for a cell therapy that is the first of its type, and its potential uses in bone marrow transplant patients.

Market On Close

03 Jan 2025

SHARE

ON AIR
1:00 pm
Morning Trade Live
5:00 am
Trading 360
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Next Gen Investing
REPLAY
education
8:00 am
Your First Trade
REPLAY
education
8:30 am
Inside the Mind of a Trader
REPLAY
education
9:00 am
Inside the Mind of a Trader
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
11:00 am
Market Overtime
REPLAY
12:00 pm
Morning Movers
ON AIR
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
9:00 pm
Market Overtime
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY
12:00 am
Market Overtime
REPLAY
education
1:00 am
Your First Trade
REPLAY
education
1:30 am
Your First Trade
REPLAY
2:00 am
Market Overtime
REPLAY
education
3:00 am
Inside the Mind of a Trader
REPLAY
education
3:30 am
Inside the Mind of a Trader
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor